Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Highlights ● cfDNA derived from glioma patients could be used to decode chromatin accessibility. ● Epigenetic-based cfDNA marker displayed potential in differentiating glioma patients. ● Chromatin accessibility analysis has opened up potential clinical utilities of cfDNA. 1 Introduction Glioma, as the most common malignancy of the brain, still has a high mortality rate (1).
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
